货号:
bs-11573R-2
抗体名:
神经特异性转录因子DPF1 / 神经特异性转录因子DPF1抗体
抗体英文名:
Neuro D/Neuro D antibody
应用范围:
WB=1:100-500ELISA=1:500-1000IHC-P=1:100-500IHC-F=1:100-500ICC=1:100-500IF=1:100-500(石蜡切片需做抗原修复)
宿主:
Rabbit
供应商:
科敏商城
数量:
大量
抗原来源:
详情参见说明书
保质期:
见说明书
适应物种:
Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep,
标记物:
HRP,Biotin,Gold,FITC,Cy3,Cy5,Cy5.5,Cy7,PE,Alexa Fluor 350,Alexa Fluor 12251,apc各标记物详情询
克隆性:
单克隆
保存条件:
低温
形态:
Lyophilized or Liquid
亚型:
IgG
免疫原:
KLH conjugated synthetic peptide derived from human Neuro D4 (301-380aa)


品Pai:bioss,产品名称:Neuro D神经特异性转录因子DPF1抗体
货号:bs-11573R
ESCS; ESCS; NR2 E3; Nr2e3; NR2E3_HUMAN; Nuclear receptor subfamily 2 group E member 3; Photoreceptor specific nuclear receptor; Photoreceptor-specific nuclear receptor antibody PNR; Rd 7; rd7; Retina specific nuclear receptor; Retina-specific nuclear receptor; Retinal degeneration 7; Retinal degeneration 7; RNR; RP37.NeuroD4; BAF45B; BRG1-associated factor 45B; D4; DPF1; DPF 1; DPF=1; DPF1_HUMAN; NEUD4; NEUD 4; Zinc and double PHD fingers family 1; Zinc finger protein neuro-d4.
PolyclonalPolyclonal
WB=1:100-500ELISA=1:500-1000IHC-P=1:100-500IHC-F=1:100-500ICC=1:100-500IF=1:100-500(石蜡切片需做抗原修复)WB=1:100-500ELISA=1:500-1000IHC-P=1:100-500IHC-F=1:100-500ICC=1:100-500IF=1:100-500(石蜡切片需做抗原修复)
45kDa42kDa
Human, Mouse, Rat, Cow, Sheep, Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep,
affinity purified by Protein Aaffinity purified by Protein A
Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
